Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Mallinckrodt
Dow
Express Scripts
Moodys

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Claims for Patent: 8,765,471

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,765,471
Title:Neutral protease (NP) and product by using neutral protease for tissue dissociation as well as method for the production thereof
Abstract: The use of a neutral protease (NP) together with a collagenase consists in that a neutral protease which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production is mixed before the beginning of a tissue dissociation with a collagenase or a collagenase enzyme preparation with an individual dosage of the quantitative proportions of neutral protease and collagenase for improving the isolation results with respect to yield, viability and integrity of the cells.
Inventor(s): Kurfuerst; Manfred (Moorrege, DE), Raemsch; Christian (Uetersen, DE), Raemsch-Guenther; Nicole (Uetersen, DE), Friedrich; Olaf (Tornesch, DE), Huettler; Silke (Uetersen, DE), Brandhorst; Daniel (Linden, DE), Berney; Thierry (Arenthon, FR), Bucher; Pascal (Geneva, CH), Brandhorst; Heide (Linden, DE)
Assignee: Nordmark Arzneimittel GmbH & Co. KG (Uetersen, DE)
Application Number:13/862,773
Patent Claims:1. A method for isolation of islets of Langerhans from a pancreatic tissue, comprising: mixing a separately prepared A component with a separately prepared B component in a predetermined mixing ratio of component A to component B to provide a reactant mixture, wherein the A component is a completely purified neutral protease (NP) from Clostridium histolyticum which is not contained in a collagenase enzyme preparation and which is not produced by a recombinant production, and the B component is a purified or partially purified collagenase; combining the reactant mixture directly thereafter with the pancreatic tissue; and isolating the islets of Langerhans.

2. The method of claim 1, wherein the mixing ratio of component A to component B is 3% (w/w), 6% (w/w), 12% (w/w), or 24% (w/w).

3. The method of claim 2, wherein the mixing ratio of component A to component B is 3% (w/w).

4. The method of claim 3, wherein the pancreatic tissue is porcine pancreas.

5. The method of claim 3, wherein the pancreatic tissue is human pancreas.

6. The method of claim 2, wherein the mixing ratio of component A to component B is 6% (w/w).

7. The method of claim 6, wherein the pancreatic tissue is porcine pancreas.

8. The method of claim 6, wherein the pancreatic tissue is human pancreas.

9. The method of claim 2, wherein the mixing ratio of component A to component B is 12% (w/w).

10. The method of claim 9, wherein the pancreatic tissue is porcine pancreas.

11. The method of claim 9, wherein the pancreatic tissue is human pancreas.

12. The method of claim 2, wherein the mixing ratio of component A to component B is 24% (w/w).

13. The method of claim 12, wherein the pancreatic tissue is porcine pancreas.

14. The method of claim 12, wherein the pancreatic tissue is human pancreas.

15. The method of claim 2, wherein the pancreatic tissue is porcine pancreas.

16. The method of claim 2, wherein the pancreatic tissue is human pancreas.

17. The method of claim 1, wherein the pancreatic tissue has been previously stored using a two-layer method with perfluoro hydrocarbons.

18. The method of claim 1, wherein the pancreatic tissue is porcine pancreas or human pancreas.

19. The method of claim 18, wherein the pancreatic tissue is porcine pancreas.

20. The method of claim 18, wherein the pancreatic tissue is human pancreas.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Harvard Business School
Baxter
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.